Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Mallal

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
AIDS (London, England)|January 1, 2005
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell countsAnnalise M Martin, David Nolan, Ian James, et al.
Plos One|June 25, 2015
Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virusKatja Pfafferott, Pooja Deshpande, Elizabeth McKinnon, et al.
BMC Infectious Diseases|May 6, 2015
Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 - a case control studyStephen B Strock, Silvana Gaudieri, Simon Mallal, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Journal of Virology|November 19, 2010
Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteinsTomer Hertz, David Nolan, Ian James, et al.
Antiviral Therapy|February 7, 2009
Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort StudyAndri Rauch, David Nolan, Christine Thurnheer, et al.
The Journal of Biological Chemistry|September 14, 2010
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesYukie Iwabu, Masanobu Kinomoto, Masashi Tatsumi, et al.
AIDS (London, England)|June 10, 2014
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivityNiamh M Keane, Rebecca K Pavlos, Elizabeth McKinnon, et al.
Antiviral Therapy|November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistanceMonika Tschochner, Abha Chopra, Tanya M Maiden, et al.
AIDS (London, England)|June 5, 2007
Immune responses to abacavir in antigen-presenting cells from hypersensitive patientsAnnalise M Martin, Coral-Ann Almeida, Paul Cameron, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|January 1, 2005
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell countsAnnalise M Martin, David Nolan, Ian James, et al.
Plos One|June 25, 2015
Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virusKatja Pfafferott, Pooja Deshpande, Elizabeth McKinnon, et al.
BMC Infectious Diseases|May 6, 2015
Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 - a case control studyStephen B Strock, Silvana Gaudieri, Simon Mallal, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Journal of Virology|November 19, 2010
Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteinsTomer Hertz, David Nolan, Ian James, et al.
Antiviral Therapy|February 7, 2009
Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort StudyAndri Rauch, David Nolan, Christine Thurnheer, et al.
The Journal of Biological Chemistry|September 14, 2010
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesYukie Iwabu, Masanobu Kinomoto, Masashi Tatsumi, et al.
AIDS (London, England)|June 10, 2014
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivityNiamh M Keane, Rebecca K Pavlos, Elizabeth McKinnon, et al.
Antiviral Therapy|November 18, 2009
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistanceMonika Tschochner, Abha Chopra, Tanya M Maiden, et al.
AIDS (London, England)|June 5, 2007
Immune responses to abacavir in antigen-presenting cells from hypersensitive patientsAnnalise M Martin, Coral-Ann Almeida, Paul Cameron, et al.
Pageof 18